Terms: = Lymphoma AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4
46700 results:
1. Serum Levels of miR-122-5p and miR-125a-5p Predict Hepatotoxicity Occurrence in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Mikulski D; Kościelny K; Dróżdż I; Mirocha G; Nowicki M; Misiewicz M; Perdas E; Strzałka P; Wierzbowska A; Fendler W
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673940
[TBL] [Abstract] [Full Text] [Related]
2. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
3. [Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and Prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell lymphoma].
Lu T; Mi H; Zhao DD; Yang SG; Bu YW; Zhang F; Chen WM; Sun DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):458-465. PubMed ID: 38660852
[TBL] [Abstract] [Full Text] [Related]
4. [Expression of CD30 in Patients with Diffuse Large B-Cell lymphoma and Clinical Significance].
Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
[TBL] [Abstract] [Full Text] [Related]
5. [A Real-World Single-Center Study of Adult Hodgkin's lymphoma].
Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line
Valizadeh Toosi SM; Feyzi S; Kazemi A
Korean J Gastroenterol; 2024 Apr; 83(4):150-156. PubMed ID: 38659251
[TBL] [Abstract] [Full Text] [Related]
7. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
Hu Y; Zhang M; Yang T; Mo Z; Wei G; Jing R; Zhao H; Chen R; Zu C; Gu T; Xiao P; Hong R; Feng J; Fu S; Kong D; Xu H; Cui J; Huang S; Liang B; Yuan X; Cui Q; Guo H; Yu Y; Feng Y; Jin C; Ren J; Chang AH; Wang D; Huang H
N Engl J Med; 2024 Apr; 390(16):1467-1480. PubMed ID: 38657244
[TBL] [Abstract] [Full Text] [Related]
8. Web-based cognitive rehabilitation intervention for cancer-related cognitive impairment following chemotherapy for aggressive lymphoma: protocol for a randomised pilot trial.
Gates P; Green HJ; Gough K; Dhillon H; Vardy JL; Dickinson M; Guarnera J; Krishnasamy M; Livingston PM; White V; Ugalde A; Caeyenberghs K
BMJ Open; 2024 Apr; 14(4):e081084. PubMed ID: 38653511
[TBL] [Abstract] [Full Text] [Related]
9. Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects.
Li J; Mu J; Wang J; Li X; Li Q; Jiang Y; Cui R; Deng Q
Cell Transplant; 2024; 33():9636897241247951. PubMed ID: 38651796
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
Ghilardi G; Paruzzo L; Patel V; Svoboda J; Chong ER; Fardella E; Chong EA; Gabrielli G; Nasta SD; Landsburg DJ; Carter J; Pajarillo R; Barta SK; White G; Weber E; Napier E; Porter DL; Garfall AL; Schuster SJ; Ruella M
J Hematol Oncol; 2024 Apr; 17(1):19. PubMed ID: 38644469
[TBL] [Abstract] [Full Text] [Related]
11. [Analysis of the safety, accuracy, and factors influencing bleeding complications in CT-guided puncture biopsy of brain occupying lesions].
Li YD; Gao MY; Wang M; Gao F; Liu YQ; Du KP; Li S; Zhang HJ; Yao YF; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1403-1409. PubMed ID: 38644291
[No Abstract] [Full Text] [Related]
12. Distinguishing Kikuchi-Fujimoto disease from lymphoma in patients by clinical and PET/CT features.
Cheng MH; Xie LJ
Medicine (Baltimore); 2024 Apr; 103(16):e37779. PubMed ID: 38640333
[TBL] [Abstract] [Full Text] [Related]
13. [BLITZ-AF Cancer study: an international observational research project on patients with atrial fibrillation and cancer].
Gulizia MM; Turazza FM; Ameri P; Alings M; Collins R; De Luca L; Di Nisio M; Lucci D; Gabrielli D; Janssens S; Parrini I; Pinto FJ; Zamorano JL; Colivicchi F
G Ital Cardiol (Rome); 2024 May; 25(5):340-345. PubMed ID: 38639124
[TBL] [Abstract] [Full Text] [Related]
14. Mosquito Bed Net Use and Burkitt lymphoma Incidence in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Schmit N; Kaur J; Aglago EK
JAMA Netw Open; 2024 Apr; 7(4):e247351. PubMed ID: 38635267
[TBL] [Abstract] [Full Text] [Related]
15. Higher mortality risk from gynaecological neoplasms and non-Hodgkin's lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry.
Moreno-Torres V; Martínez-Urbistondo M; Vázquez-Comendador J; Mateos Seirul-Lo M; Castejón R; Huerta A; Durán-Del Campo P; Tutor P; Mellor-Pita S
Lupus Sci Med; 2024 Apr; 11(1):. PubMed ID: 38631847
[TBL] [Abstract] [Full Text] [Related]
16. Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia.
Ma S; Wang Y; Qi K; Lu W; Qi Y; Cao J; Niu M; Li D; Sang W; Yan Z; Zhu F; Cheng H; Li Z; Zhao M; Xu K
Cancer Immunol Immunother; 2024 Apr; 73(6):104. PubMed ID: 38630258
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study.
Zheng W; Liu M; Guan L; Wang S
Cancer Med; 2024 Apr; 13(8):e7120. PubMed ID: 38629251
[TBL] [Abstract] [Full Text] [Related]
18. Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.
Wang H; Feng J; Liu Y; Qian Z; Gao D; Ran X; Zhou H; Liu L; Wang B; Fang M; Zhou H; Huang Z; Tao S; Chen Z; Su L; Su H; Yang Y; Xie X; Wu H; Sun P; Hu G; Liang A; Li Z
Signal Transduct Target Ther; 2024 Apr; 9(1):99. PubMed ID: 38627366
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Features of Non-Hodgkin lymphoma-Associated Hemophagocytic Syndrome: a Retrospective Study.
Wu C; Liu H; Chen J
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623661
[TBL] [Abstract] [Full Text] [Related]
20. Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Oporto Espuelas M; Burridge S; Kirkwood AA; Bonney D; Watts K; Shenton G; Jalowiec KA; O'Reilly MA; Roddie C; Castleton A; Clesham K; Nicholson E; Alajangi R; Prabhu S; George L; Uttenthal B; Gabelli M; Neill L; Besley C; Chaganti S; Wynn RF; Bartram J; Chiesa R; Lucchini G; Pavasovic V; Rao A; Rao K; Silva J; Samarasinghe S; Vora A; Clark P; Cummins M; Marks DI; Amrolia P; Hough R; Ghorashian S
Blood Cancer J; 2024 Apr; 14(1):66. PubMed ID: 38622139
[TBL] [Abstract] [Full Text] [Related]
[Next]
